期刊文献+

374例系统性红斑狼疮患者自身抗体检测及结果分析 被引量:7

Analysis of Autoantibody Profiles of 374 Cases of Systemic Lupus Erythematosus
下载PDF
导出
摘要 目的探讨血清自身抗体检测对系统性红斑狼疮(SLE)的诊断价值和临床意义。方法采用间接免疫荧光法(IIFA)检测SLE患者血清中的抗核抗体(ANA);抗ds-DNA抗体的检测采用免疫斑点金渗滤法;采用酶免疫斑点法检测6种特异性核抗原的自身抗体(抗Sm、RNP、SS-A、SS-B、Scl-70和JO-1抗体)。结果①374例SLE患者中,IIFA检测ANA阴性31例,ANA阳性者343例(阳性率91.7%),主要荧光模式为核颗粒型、核颗粒/均质型;②抗Sm、RNP、SS-A、SS-B、Sc1-70、Jo-1、dsDNA的阳性率分别为15.0%、23.8%、50.5%、12.0%、0%、0.3%和43.8%。结论 ANA的联合检测对SLE的诊断和疗效观察具有重要意义。 Objective To explore the diagnostic value and clinical significance of autoantibody test for SLE patients. Methods Serum samples of 374 SLE patients were analyzed by detecting antinuclear antibody ( ANA), anti-ds-DNA antidody and ENA antibody repertoire( anti-Sm, anti-RNP, anti-SS-A, anti-SS-B, anti- Sc170 and anti-Jol antibody)with indirect immunofluorescence assay(IIFA) and gold linked immunodotting percolation and enzyme linked immunodotting respectively. Results (~Among the 374 SLE patients, there were 31 cases of ANA negative of IIFA test, and the positive rate of ANA (IIFA)for SLE patients was 91.7% ,and speckled pattern and speckled/homogeneuous pattern were the major immunofluorescence pat- terns ; (~the positive rate of anti-Sm antibody, anti-RNP antibody, anti-SS-A antibody, anti-SS-B antibody, anti-Scl70 antibody,anti-Jol antibody and anti-dsDNA were 15.0% ,23.8% ,50.5%, 12.0% ,0% ,0.3% and 43.8%. Conclusion Co-detection has great clinical significance for diagnosis and evaluation of cura- tive effect of SLE.
出处 《医学综述》 2013年第20期3817-3819,共3页 Medical Recapitulate
关键词 系统性红斑狼疮 抗核抗体 间接免疫荧光法 Systemic lupus erythematosus Antinuclear antibody Indirect immanofluoreseence assay
  • 相关文献

参考文献12

二级参考文献68

共引文献125

同被引文献60

  • 1闫有功,刘汛,曹军皓,张利芳.系统性红斑狼疮与抗磷脂抗体综合症[J].华南国防医学杂志,2000,14(4):84-86. 被引量:4
  • 2孙敏霞,吴纯,菅小红,董梅,匡铁吉.抗核小体抗体、抗Sm抗体、抗双链DNA抗体在系统性红斑狼疮诊断中的临床意义[J].中国实验诊断学,2007,11(8):1067-1068. 被引量:20
  • 3Saigal R, Goyal LK, Agrawal A, et al. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease acti, ity marker and its comparison with anti-dsDNA antibody [J]. J Assoc Physicians India,2013,61(6) :372-377.
  • 4D'Cruz D PoKhamashta M A, Hughes G R V. Systemic lupus erythematosus[J]. Lancet, 2007,369 : 587-596.
  • 5Danehenko N,Satia J A, Anthony M S. Epidemiology of sys- temic lupus erythematosus:a comparison of worldwide disease hurden[J]. Lupus, 2006,15 : 308-318.
  • 6Tan E M,Cohen A S,Fries J F,et al. The 1982 revised criteria for the classification of systemic lupus erythematosus[J]. Ar- thritis Rheum, 1982,25 : 1271-1277.
  • 7Hochberg M C. Updating the American College of Rheumatol ogy revised criteria for the classification of systemic lupus ery- thematosus[J]. Arthritis Rheum, 1997,40 : 1725.
  • 8Li M, Zhan W. Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus[J]. Lupus, 2013, 22,1192-1199.
  • 9Hahn BH, Memahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment and management of Lupus Nephritis, 2012,64(6) : 801,797-808.
  • 10Hanly JG, Su L, Farewell V, et al. Comparison between multiplex as- says for autoantibody detection in systemic lupus erythematosus [J]. J Immunol Methods, 2010,358 (1-2) : 75-80.

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部